Thrombosis Research

Article	Citations
Age over 75 does not increase the risk of recurrent venous thromboembolism: Findings from the RIETE registry	86
The value of the CHAP model for prediction of the bleeding risk in patients with unprovoked venous thromboembolism: Findings from the RIETE registry	79
Venous thromboembolism associates with SARS-CoV-2 more than seasonal influenza	63
Safety and effectiveness of a risk-stratified venous thromboembolism prophylaxis algorithm in young people with cystic fibrosis	63
Extended-duration thromboprophylaxis following major abdominopelvic surgery – For everyone or selected cases only?	62
DOAC drug levels: Does “knowing” lead to safer care?	53
Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?	49
Validation of the Academic Research Consortium for High Bleeding Risk criteria in Chinese patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention	47
PO-99 Non-traumatic subdural hematoma and occult cancer: a Danish nationwide cohort study	47
PO-82 Impede VTE vs saved scores to predict the risk of venous thromboembolism in newly diagnosed multiple myeloma with immunomodulatory drugs: how to choose?	47
Exploration of rotational thromboelastometry (ROTEM) to characterize the coagulation profiles of newly diagnosed pediatric leukemia patients	46
Thromboelastometry in daily obstetric practice: At what amount of blood loss do we find abnormal results? A retrospective clinical observational study	44
Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study	41
DOACs: A perfect fit for patients with bariatric surgery?	40
Impact of direct oral anticoagulants on evolution of post-thrombotic syndrome	39
Quality and predictors of oral anticoagulation therapy with vitamin K antagonists in adult congenital heart disease: TTR and INR variability	36
Anticoagulation with argatroban using hemoclot™ targets is safe and effective in CARDS patients receiving venovenous extracorporeal membrane oxygenation: An exploratory bi-centric cohort study	35
External validation of a model to predict women most at risk of postpartum venous thromboembolism: Maternity clot risk	34
Tigecycline-associated hypofibrinogenemia: A single center, retrospective, controlled study	34
Decreased patency of transjugular intrahepatic portosystemic shunts performed for splanchnic vein thrombosis in patients with myeloproliferative neoplasms	32
Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study	32
Absence of COVID-19-associated changes in plasma coagulation proteins and pulmonary thrombosis in the ferret model	31
Efficacy and safety of genotype-guided warfarin dosing versus non-genotype-guided warfarin dosing strategies: A systematic review and meta-analysis of 27 randomized controlled trials	30
Development and validation of an in vitro model to study thrombin generation on the surface of catheters in platelet-poor and platelet-rich plasma	29
Comparative analysis of Lox-1 and CD36 expression in human platelets and on circulating microparticles during ARDS-induced coagulopathy	29

Inferior vena cava contrast reflux grade is associated with a reduced cardiac index in acute pulmonary embolism	28
Corrigendum to “Repurposing of rilpivirine for preventing platelet β3 integrin-dependent thrombosis by targeting c-Src active autophosphorylation” [Thromb. Res. 229 (2023) 53–68]	28
Complement system activation through the alternative pathway associates with disseminated intravascular coagulation to increase mortality in sepsis	27
Dielectric blood coagulometry to evaluate coagulation activity in patients prescribed factor Xa inhibitors undergoing elective surgery: A prospective observational study	26
Is all collagen the same for platelet testing? Editorial on “Platelet collagen receptors and their role in modulating platelet adhesion patterns and activation on alternatively processed collagen subs	26
Disparities in menstrual bleeding management during acute venous thromboembolism treatment: A review of UK practice and a call for clinical studies	26
Time in therapeutic range is lower in women than in men and is not explained by differences in age or comorbidity	25
Evolving data on cardiovascular complications in cancer	25
Four cases of acquired hemophilia A following immunization with mRNA BNT162b2 SARS-CoV-2 vaccine	24
Modern imaging of acute pulmonary embolism	24
Clinical outcomes of cancer-associated isolated superficial vein thrombosis in daily practice	24
Detection of anti-GPIbα autoantibodies in a case of immune thrombocytopenia following COVID-19 vaccination	24
Long-term follow-up after successful treatment of vaccine-induced prothrombotic immune thrombocytopenia	24
Impact of a commercially available DOAC absorbent on two integrated procedures for lupus anticoagulant detection	23
Rivaroxaban plus aspirin versus acenocoumarol to manage recurrent venous thromboembolic events despite systemic anticoagulation with rivaroxaban	23
Efficacy and safety of intra-operative thromboprophylaxis with low-molecular-weight-heparin or heparin in patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP	22
Publisher’s note	22
Deciphered coagulation profile to diagnose the antiphospholipid syndrome using artificial intelligence	21
Development and internal validation of a clinical prediction model for individualized dosing of BAY 81-8973, A full-length recombinant factor VIII, in pediatric patients with haemophilia A	21
Pulmonary embolism: Age specific temporal trends in incidence and mortality in Denmark 1999–2018	21
Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study	21
Predicting post-discharge venous thromboembolism and bleeding among medical patients: External validation of a novel risk score utilizing ubiquitous biomarkers	20
Crosstalk between hemostasis and immunity in cancer pathogenesis	20
Effect of regular exercise training on platelet function in patients with cardiovascular disease and healthy individuals: A systematic review	20
Major in-hospital bleeding in patients with pulmonary embolism treated with systemic thrombolysis	20
Incidence and risk factors of venous thrombotic events in pediatric patients with CNS tumors compared with non-CNS cancer: A population-based cohort study	19
A response to a letter to the editor TR-D-22-00887	19
Cerebral venous thrombosis: A rare complication of Ramsay Hunt syndrome (case report and literature review)	19
Navigating the twilight zone of DOAC plasma monitoring	19
Early immune tolerance induction is a unique predictor of favorable outcomes in hemophilia A children with intron 22 inversion and high-responding inhibitors	19
Editorial Board	19
Effect of sample heat inactivation on test levels of HIT-IgG(PF4-H) detected by the ACL AcuStar	19
Defibrotide mitigates endothelial cell injury induced by plasmas from patients with COVID-19 and related vasculopathies	19
Massive intrasplenic arterial thrombosis in a patient with chronic ITP during the development of an Evans syndrome	18
Editorial Board	18
Risk factors of arterial thrombotic events after unprovoked venous thromboembolism, and after cancer associated venous thromboembolism: A prospective cohort study	18
Inappropriate low dosing of direct oral anticoagulants in older patients with non-valvular atrial fibrillation: Impact on plasma drug levels	18
Increased prevalence of heparin induced thrombocytopenia in COVID-19 patients	18
Health care professionals' conceptions of respiratory symptoms and physical activity in patients with acute pulmonary embolism. A phenomenographic interview study.	18
Initiation of anticoagulation in atrial fibrillation by primary care physicians: Results of a telephone survey	18
Increased platelet glycoprotein IIb/IIIa activation precedes continuous-flow left ventricular assist device pump thrombosis events	18
OC-04 Incidence, predictors and clinical outcomes of venous thromboembolism in patients with newly diagnosed pancreatic ductal adenocarcinoma: results of the prospective BACAP-VTE study	17
PO-13 Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study (STAC)	17
PO-08 Cancer outpatients under thromboprophylaxis: an analysis of choices and events	17
PO-11 Venous thromboembolism in ovarian cancer patients: a nationwide Danish cohort study	17
OC-13 A clinical-genetic risk score to predict cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts	17
PO-105 Quantification of citrullinated histones in human blood samples: challenges and development of a nucleosome-based assay to quantify H3Cit-DNA in human plasma	17
PO-21 Incidence of venous thromboembolism events in outpatients with cancer and COVID-19.	16
PO-62 Tinzaparin: anti-cancer properties?	16
PO-20 Incidence of venous thromboembolism in men with prostate cancer and men without prostate cancer: a nationwide population-based cohort study in Sweden	16

PO-52 Immunophenotypic analysis of haematological malignancies in a Pakistani population: a step towards formulation of hospital cancer registry	16
PO-46: Perception of the risk of thrombosis in clinicians treating patients with multiple myeloma	16
PO-41 Paraneoplastic deep vein thrombosis in pre-existing full-dose anticoagulation with dabigatran: a case report	16
PO-48: Coagulopathy in multiple myeloma	16
PO-58 Venous and arterial tromboembolic events among hospitalized cancer patients with SARS-COV2 infection	16
PO-50: Molecular landscape of the coagulome of oral squamous cell carcinoma	15
PO-39: Superior vena cava stenting: an effective and safe therapeutic choice for the treatment of superior vena cava syndrome in lung cancer patients	15
Optimizing antithrombotic therapy for atrial fibrillation in cancer	15
PO-35: A method for prioritisation and translation of pleiotropic effects into clinical applications: lessons from low molecular weight heparin treatment in cancer	15
PO-14: Real-world data: incidence of venous thromboembolism recurrence and bleeding among cancer patients	15
Real-world rivaroxaban use in fragile Asian patients with atrial fibrillation: The impact of plasma concentration on clinical outcomes	15
PO-51: Kaposiform hemangioendothelioma is associated with platelet functional abnormalities that persist in patients even after complete blood cell count recovery	15
PO-08: Characterisation of plasma extracellular vesicles in myeloproliferative neoplasms	15
Venous and arterial thromboembolism with immunotherapy compared to platinum-based therapy	15
Circulating immune cells with megakaryocyte signature in response to COVID-19 mRNA vaccination	14
OC-12: Stroke and risk of cancer: a Danish population-based cohort study	14
Long term recovery of right ventricular function after treatment of intermediate and high risk pulmonary emboli	14
Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials	14
Editorial Board	14
Right ventricular pressure overload related to residual thrombotic burden in patients 1 year after acute pulmonary embolism: From the Nagoya PE study	14
OC-09: Rivaroxaban compared to no treatment in early breast cancer patients (the TIP Trial): initial findings for a phase II preoperative window-of-opportunity randomised controlled trial	14
Letter to the Editor Re “Endovascular thrombectomy or bridging therapy in minor ischemic stroke with large vessel occlusion”	14
Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability	14
Editorial Board	14
Copyright	14
Editorial Board	14
Bleeding outcomes and management of supratherapeutic episodes secondary to warfarin in children: A single center 10-year experience	14
Impact on thrombotic risk of canonical and atypical CALR mutations in essential thrombocythemia. A single-center cohort study	14
The prognostic value of ORBIT risk score in predicting major bleeding in patients with acute coronary syndrome	13
COVID-19 venous thromboembolism prophylaxis guidelines in pediatrics	13
DOACs for Older adults with Atrial Fibrillation and Falls: Results from the prospective single-centre DOAFF study	13
Head-to-head comparison of four COVID-19 vaccines on platelet activation, coagulation and inflammation. The TREASURE study	13
Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors	13
Downregulation of protein S in patients with severe COVID-19 augments the prothrombotic state	13
Association of telomere length and mitochondrial DNA copy number, two biomarkers of biological aging, with the risk of venous thromboembolism	13
Bivalirudin or heparin for systemic anticoagulation during pediatric extracorporeal membrane oxygenation: Multicenter retrospective study	13
Detection and management of clinically relevant drug-drug interactions with direct oral anticoagulants: an intervention study in community pharmacies	13
Low-grade endotoxemia and risk of recurrent thrombosis in primary antiphospholipid syndrome. The multicenter ATHERO-APS study	13
Effect of blood loss during caesarean section on coagulation parameters	13
Not all patent foramen ovales are alike!	13
S62798, a potent TAFIa inhibitor, accelerates endogenous fibrinolysis in a murine model of pulmonary thromboembolism	12
Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination	12
Comparative analysis of thrombin generation platforms for patients with coagulation factor deficiencies: A comprehensive assessment	12
Positive predictive value and sensitivity of cancer-associated venous thromboembolism diagnoses in the Danish National Patient Register	12
Development and validation of a clinical prediction model for post thrombotic syndrome following anticoagulant therapy for acute deep venous thrombosis	12
COVID-19 in thrombosis research: An editorial perspective	12
Cancer-associated splanchnic vein thrombosis: Clinical features upon diagnosis and short-term outcomes	12
Predictors of cancer in patients with acute pulmonary embolism	12
Accuracy of transthoracic lung ultrasound for diagnosing pulmonary embolism: An updated systematic review and meta-analysis	12
Elevated von Willebrand factor levels in multiple myeloma: dysregulated mechanisms of both secretion and clearance	12
Implications of bleeding on subsequent cardiovascular events in patients with atrial fibrillation after acute coronary syndrome or PCI	12
Clonal hematopoiesis and cardiovascular disease in cancer patients and survivors	12
Mechanical thrombectomy vs catheter directed thrombolysis vs anticoagulation alone: A tertiary center PERT Registry Cohort Analysis	12
Evaluation of standard versus reduced dose apixaban for the treatment of venous thromboembolism in patients with severe renal disease (ESRD-VTE)	12
Antithrombin testing and treatment in pregnancy: Their real-world relationship to clinical outcomes	12
Whole exome sequencing identifies genetic variants in Chinese Han pregnant women with venous thromboembolism	11
Clinical and endoscopic findings in patients with acute gastrointestinal bleeding associated with direct oral anticoagulants: Results from a single-center prospective cohort study	11
Being John Plasma Volumovich, pecularities of plasma volume estimation in patients with polycythemia vera	11
Developing and validating natural language processing algorithms for radiology reports compared to ICD-10 codes for identifying venous thromboembolism in hospitalized medical patients	11
Unveiling the predictive capacity of inflammatory and platelet markers for central retinal artery occlusion	11
F9 mRNA splicing aberration due to a deep Intronic structural variation in a patient with moderate hemophilia B	11
Novel CT-derived parameter is associated with low cardiac index in acute pulmonary embolism	11
Management options for pediatric venous thromboembolic disease: Beyond anticoagulation with endovascular therapies	11
Pre-administration of a carboxypeptidase inhibitor enhances tPA-induced thrombolysis in mouse microthrombi: Evidence from intravital imaging analysis	11
Effectiveness and safety of edoxaban therapy in daily-care patients with atrial fibrillation. Results from the DRESDEN NOAC REGISTRY	11
Hemostatic status in women with breast cancer and cardiotoxicity associated to doxorubicin-based chemotherapy – A one-year follow-up study	11
Breaking down tumor thrombus: Current strategies for medical management	11
Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination	11
Sulfated non-anticoagulant low molecular weight heparin in the prevention of cancer and non-cancer associated thrombosis without compromising hemostasis	11
PO-88 Validation and comparison of the Protecht, Conko, and Khorana score for prediction of venous thromboembolism in ambulatory cancer patients: a retrospective cohort study	11
Depression and anxiety up to two years after acute pulmonary embolism: Prevalence and predictors	11
Adhesive properties of plasma-circulating and platelet-derived microvesicles from healthy individuals	10
Fragility and long-term clinical outcomes in patients with venous thromboembolism receiving direct oral anticoagulants: From the COMMAND VTE REGISTRY-2	10
Vaccine-associated thrombocytopenia	10
The effects of an aggressive breast tumor on thrombosis after antithrombin downregulation in a hypercoagulable mouse model	10
Unreported incidental pulmonary embolism in patients with cancer: Radiologic natural history and risk of recurrent venous thromboembolism and death	10
Persistent circulating platelet and endothelial derived microparticle signature may explain on-going pro-thrombogenicity after acute coronary syndrome	10
Scoping review of current evidence on the incidence of Venous thromboembolism (VTE) in the East Asian population	10
Platelet function and soluble P-selectin in patients with primary immune thrombocytopenia	10
Comparison of important factors to patients recovering from pulmonary embolism and items covered in patient-reported outcome measures: A mixed-methods systematic review	10

A retrospective study of the role of preoperative ultrasonography in the detection of deep vein thrombosis in 1750 patients with gastric and colorectal cancers	10
Characterization of a canine freeze-dried platelet-derived hemostatic agent: A preclinical model for surgical and traumatic hemorrhage	10
Inhibitory effects of resveratrol on platelet activation and thrombosis in colon cancer through regulation of the MAPK and cGMP/VASP pathways	10
Trends and factors associated with outpatient anticoagulant treatment initiation among VTE patients with active cancer	10
Development of an ADAMTS13-based Therapy for Thrombosis	10
Effectiveness and safety of anticoagulants among venous thromboembolism cancer patients with and without brain cancer	10
Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry	10
Acute and subacute effects of strenuous exercise on platelet aggregation, coagulation and fibrinolysis in patients with stable coronary artery disease	10
Outcomes of isolated distal thrombosis managed with serial compression ultrasonography	10
Untreated obstructive sleep apnea and cardiovascular outcomes in patients with acute symptomatic pulmonary embolism	10
Prothrombotic genotypes and risk of venous thromboembolism in occult cancer	10
Antithrombin exhibits anticoagulant effects on the emicizumab-based engineered bispecific antibody (NXT007)-mediated blood coagulation	10
The emicizumab-bridged ternary complex with activated factor IX and factor X evaluated by fluorescence resonance energy transfer	10
Procoagulant activity in high grade serous ovarian cancer patients following neoadjuvant chemotherapy-The role of the activated protein C pathway	9
High-on-treatment platelet reactivity predicts adverse outcome after carotid artery stenting: A prospective study	9
In-hospital outcomes of Ticagrelor versus Clopidogrel in high bleeding risk patients with acute coronary syndrome: Findings from the CCC-ACS project	9
Strategies for improving guideline adherence of anticoagulants for patients with atrial fibrillation in primary healthcare: A systematic review	9
Direct oral anticoagulants for the treatment of cerebral vein thrombosis	9
The differential formation and composition of leukocyte-platelet aggregates induced by various cellular stimulants	9
Barriers and facilitators to preventing venous thromboembolism in oncology practice	9
Real life results of direct-acting oral anticoagulants recommended-dose in obese vs normal-weight patients with venous thromboembolism	9
Effect of α2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism	9
Derivation and external validation of a portable method to identify patients with pulmonary embolism from radiology reports: The READ-PE algorithm	9
Estetrol is not a SERM but a NEST and has a specific safety profile on coagulation	9
A novel role of acellular hemoglobin in hemolytic thrombosis	9
Endothelial dysfunction, a predictor of cardiovascular disease in HIV patients on antiretroviral therapy: A systematic review and meta-analysis	9
The immune thrombocytopenia paradox: Should we be concerned about thrombosis in ITP?	9
Regulation of fibrinogen synthesis	9
Hemodialysis-related low thrombogenicity measured by total thrombus-formation analysis system in patients undergoing percutaneous coronary intervention.	9
Challenging clinical scenarios for therapeutic anticoagulation: A practical approach	9
Evaluation of hemostatic abnormalities in patients who underwent major hepatobiliary pancreatic surgery using activated partial thromboplastin time-clot waveform analysis	9
An international survey of low molecular weight heparin prescribing in the context of antenatal venous thromboembolism	9
Efficacy and safety of apixaban for primary prevention in gastrointestinal cancers: A post-hoc analysis of the AVERT trial	9
Estimating the measurement uncertainties of the international sensitivity index of 12 thromboplastins through Monte Carlo simulation	9
Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis	9
The efficacy and safety of andexanet alfa in the treatment of anticoagulation-related major bleedings: An Italian perspective	9
Patients with multiple myeloma and monoclonal gammopathy of undetermined significance have variably increased thrombin generation and different sensitivity to the anticoagulant effect of activated pro	9
OKL-1111, A modified cyclodextrin as a potential universal reversal agent for anticoagulants	9
WY-14643, a novel antiplatelet and antithrombotic agent targeting the GPIbα receptor	9
Health-related quality of life associated with warfarin and direct oral anticoagulants in venous thromboembolism	9
Accuracy of the functional, flow cytometer-based Emo-Test HIT Confirm® for the diagnosis of heparin-induced thrombocytopenia	9
Corrigendum to “Thrombin generation, thrombin-antithrombin complex, and prothrombin fragment F1+2 as biomarkers for hypercoagulability in cancer patients” [Thromb. Res. 186 2020. 80–85]	8
SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia	8
PO-90 Characterization of thrombosis risk in patients with cancer: preliminary results	8
Reversal of cardiopulmonary exercise intolerance in patients with post-thrombotic obstruction of the inferior vena cava	8
Thrombin generation is associated with ischemic stroke at a young age	8
Comment on: “Efficacy and safety of low-dose acetylsalicylic acid for the prevention of thromboembolic events in individuals positive for antiphospholipid antibodies: A systematic review and meta-anal	8
COVID-19 and thrombosis: The role of hemodynamics	8
Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19	8
Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia	8
NLRP3 inflammasome contributes to endotoxin-induced coagulation	8
Quantitative analysis of clot density, fibrin fiber radius, and protofibril packing in acute phase myocardial infarction	8
PO-102 Bleeding management challenges in rare cancer-associated thrombosis: a case report of inferior vena cava thrombus in a patient with testicular germ cell tumour	8
Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study	8
Statin use and mortality in patients with deep vein thrombosis. Data from the RIETE Registry	8
Comparative effectiveness among thromboprophylaxis strategies after the Fontan operation: A systematic review and network meta-analysis	8
Don't let D-dimer fool you: Elevated D-dimer plasma levels should not imply ‘hyperfibrinolysis’	8
Venous thromboembolism risk assessment scale for prediction of venous thromboembolism in inpatients with cancer: A meta-analysis	8
Short term outcome of neonatal venous thromboembolism in anticoagulated versus observed patients	8
Management of venous thromboembolism in pregnancy	8
“COVID-19 associated divergent thrombotic thrombocytopenic purpura (TTP) syndromes reported so far, five and counting”: Classification and possible therapeutic options	8
Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients	8
Preoperative treatment with clopidogrel and ticagrelor on bleeding complications in off-pump coronary artery bypass grafting	8
Diagnostic accuracy of four different D-dimer assays: A post-hoc analysis of the YEARS study	8
A novel interaction between extracellular vimentin and fibrinogen in fibrin formation	8
Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: A systematic review and meta-analysis	8
Venous thromboembolism in solid-organ transplant recipients: Findings from the RIETE registry	8
Impact of pulmonary infarction in pulmonary embolism on presentation and outcomes	8
Upregulation of mechanosensitive channel Piezo1 involved in high shear stress-induced pulmonary hypertension	8
To clot, or not to clot: The dilemma of hormone treatment options for menopause	8
Investigation of the impact of antithrombin deficiency on the inflammatory response: Results from a single centre cohort study	8
Potential of continuous tPA infusion for multiple-organ failure from lipopolysaccharide-induced disseminated intravascular coagulation in rats	8
Arthropathy in people with mild haemophilia: Exploring risk factors	8
Osimertinib-related venous thromboembolism in non small lung cancer	8
Clinical predictors for thrombus progression in cirrhotic patients with untreated splanchnic vein thrombosis	8
Is pulmonary embolism occurring after SARS COV-2 vaccination provoked or unprovoked?	7
Venous thromboembolism in pediatric patients with sickle cell disease: A north American survey on experience and management approaches of pediatric hematologists	7
Editorial Board	7
Changes in the epidemiology of patients hospitalized in France with deep venous thrombosis and pulmonary embolism during the COVID-19 pandemic	7
Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic	7
Development and prospective validation of a novel risk score for predicting the risk of lower extremity deep vein thrombosis among multiple trauma patients	7
Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy	7
Risk of thrombosis in patients with essential thrombocythemia and type 1 CALR mutation	7
Platelet factor 4 promotes deep venous thrombosis by regulating the formation of neutrophil extracellular traps	7
Novel prenatal diagnosis of protein C deficiency and primary prophylaxis with protein C concentrate	7
Thrombotic burden, D-dimer levels and complete compression ultrasound for diagnosis of acute symptomatic deep vein thrombosis of the lower limbs	7
Therapeutic anticoagulation in COVID-19 patients	7
Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer	7
Drug-drug interactions between direct oral anticoagulants and anticancer drugs: A single center daily practice evaluation of the occurrence, prescriber response, and subsequent thrombotic and bleeding	7
A FRET-based assay for the quantitation of the thrombin-factor XI interaction	7
Effects of gender affirming hormone therapy with testosterone on coagulation and hematological parameters in transgender people assigned female at birth: A systematic review and meta-analysis	7
Risk of thromboembolism according to statin treatment in patients with cancer: A nationwide nested case-control study	7
D-dimer driven deep vein thrombosis prophylaxis strategy for hospitalized patients with COVID-19	7
Whole blood viscoelastic testing profile and mortality in patients hospitalized with acute COVID-19 pneumonia: A systematic review and meta-analysis	7
Risks factors and outcomes for isolated catheter-related deep venous thrombosis in patients undergoing allogeneic hematopoietic stem cell transplantation	7